Featured Topics
Calendar

March 05, 2025

FY/Q4 2024 Results / Annual Report
Sustainability Report 2024

April 25, 2025

Annual Stockholders’ Meeting 2025
Press Releases
Share Price / Index
December 17, 2024
Not intended for U.S. and UK Media
Aflibercept 8 mg met primary endpoint in phase III study and demonstrates vision gains with extended treatment intervals in retinal vein occlusion
December 13, 2024
Not intended for U.S. and UK Media
Acoramidis receives positive CHMP opinion for treatment of transthyretin amyloid cardiomyopathy
November 12, 2024
Third quarter of 2024
Bayer: Strategic progress in challenging business environment – Group outlook confirmed in nearly all parameters

Our Products

Our broad product portfolio includes many world-famous brands that have shaped our Bayer brand. With our products, we are helping to find solutions to some of the greatest challenges of our time. So that health and nutrition can be made available to everyone.